Amgen vs AstraZeneca: Revenue Comparison
Amgen (AMGN) and AstraZeneca (AZN) are peers in GLP-1. Amgen reported revenue of $8.6B as of Q1 2026, compared with $15.3B for AstraZeneca. AstraZeneca leads on revenue.
Amgen's gross margin is 68.2% versus 82.5% for AstraZeneca. Amgen's net margin is 21.1% versus 20.1% for AstraZeneca.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Amgen 8.618, AstraZeneca 15.288.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Amgen, AstraZeneca.| Metric | Amgen | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $8.62B | $15.29B |
| Cost of Revenue | $2.74B | $2.68B |
| Gross Profit | $5.87B | $12.61B |
| Operating Income | $2.67B | $4.25B |
| Net Income | $1.82B | $3.08B |
| R&D Expense | $1.72B | $3.49B |
| Earnings Per Share | $3.34 | $3.94 |
| Gross Margin | 68.2% | 82.5% |
| Operating Margin | 30.9% | 27.8% |
| Net Profit Margin | 21.1% | 20.1% |
| Free Cash Flow | $1.48B | $1.82B |
| Cumulative Free Cash Flow | $165.69B | $119.09B |
| Operating Cash Flow | $2.19B | $3.36B |
| Cash & Equivalents | $12.04B | $7.56B |